- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | TechCreate Net Loss Narrows In H1 | ||
| Fr | Uxin Enters Share Subscription Agreements With NIO Capital, Prestige Shine | ||
| Fr | Dermata Therapeutics Announces A Private Placement Valued At Up To $12.4 Mln | ||
| Fr | Ion Beam Applications Signs Proton Therapy Contract With Seoul St. Mary's Hospital | ||
| Do | FDA Recalls Frozen Shrimp Over Possible Cesium-137 Contamination | ||
| Do | Passengers Seek Damages After Suspected Bed Bugs Found On KLM Flight | ||
| Do | Leifras Secures 2.5 Bln Yen Credit Line To Fund Global Expansion | ||
| Do | Biohaven: Phase 2 Proof-of-concept Study With BHV-7000 Fails To Meet Primary Endpoint | ||
| Do | Innovent Biologics: TABOSUN Receives NMPA Approval | ||
| Mi | SOBR Safe Shares Surge 70% | ||
| Mi | FDA Approves Omeros' Yartemlea, First Approved Drug For Rare Post-Transplant TA-TMA | ||
| Mi | Edgewise Therapeutics Shares Surge 20% On Positive Phase 2 HCM Trial Update | ||
| Mi | OMER Surges 81% On FDA Approval Of Yartemlea For Transplant-Related TA-TMA | ||
| Mi | AGIO Rises Nearly 20% On FDA Approval Of AQVESME For Thalassemia Anemia | ||
| Mi | Jiangxi Copper Clears Regulatory Hurdles For Proposed SolGold Acquisition | ||
| Mi | Foresee Pharma Reports Positive Topline Results From Phase 3 Casppian Trial With FP-001 | ||
| Mi | Canadian Solar Promotes Colin Parkin To President, Appoints Dylan Marx COO | ||
| Mi | Luye Pharma Grants Nhwa Rights To Commercialize Three LAI Antipsychotics In Chinese Mainland | ||
| Mi | Li-FT Power To Acquire Azimut's 50% Stake In Galinée Lithium Property | ||
| Mi | Wayon Energy Secures RMB 380 Mln Investment From Boyu Capital For 8% Stake | ||
| Mi | BayWa AG To Sell Cefetra Group For EUR 125 Mln | ||
| Mi | Copper Giant Resources Upsizes Private Placement To $12 Mln | ||
| Mi | FDA Approves Agios' AQVESME For Treatment Of Anemia In Alpha- And Beta-Thalassemia | ||
| Mi | Multi Ways Holdings Limited Profit Rises In H1 | ||
| Mi | Zai Lab Receives Approval In China For Schizophrenia Drug COBENFY |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .